Gardner Lewis Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-87,528
Closed -$8.89M 90
2025
Q4
$8.89M Buy
+87,528
New +$7.03M 2.25% 15
2020
Q1
Sell
-20,935
Closed -$1.94M 79
2019
Q4
$1.94M Buy
20,935
+4,625
+28% +$407K 0.26% 61
2019
Q3
$1.47M Buy
+16,310
New +$1.86M 0.22% 68

Other funds holding EXAS

Gardner Lewis Asset Management's EXAS Position: Q1 2026 in Review

Gardner Lewis Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 87,528 shares — an estimated $8.89M sold.

Gardner Lewis Asset Management first reported a position in EXAS in Q3 2019 and held it in 3 quarters. The position peaked at $8.89M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Gardner Lewis Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 87,528 Exact Sciences shares in Q1 2026, an estimated $8.89M.
  • Gardner Lewis Asset Management first reported a position in Exact Sciences in Q3 2019 and held it in 3 quarters.
  • Gardner Lewis Asset Management's Exact Sciences position peaked at $8.89M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2026, filed 8 May 2026.